MarketBeat Instant News Alerts 2 hours agoAmdocs (NASDAQ:DOX) Earns "Hold (C+)" Rating from Weiss RatingsMarketBeatWeiss Ratings reissued a "hold (c+)" rating on shares of Amdocs in a report on Wednesday.NASDAQ:DOXRead Amdocs (NASDAQ:DOX) Earns "Hold (C+)" Rating from Weiss Ratings2 hours agoWeiss Ratings Reiterates Sell (D) Rating for AMC Networks (NASDAQ:AMCX)MarketBeatWeiss Ratings reiterated a "sell (d)" rating on shares of AMC Networks in a research report on Wednesday.NASDAQ:AMCXRead Weiss Ratings Reiterates Sell (D) Rating for AMC Networks (NASDAQ:AMCX)2 hours agoAmbarella's (AMBA) Sell (D-) Rating Reaffirmed at Weiss RatingsMarketBeatWeiss Ratings reissued a "sell (d-)" rating on shares of Ambarella in a research note on Wednesday.NASDAQ:AMBARead Ambarella's (AMBA) Sell (D-) Rating Reaffirmed at Weiss Ratings2 hours agoAmazon.com's (AMZN) Buy (B-) Rating Reaffirmed at Weiss RatingsMarketBeatWeiss Ratings reiterated a "buy (b-)" rating on shares of Amazon.com in a report on Wednesday.NASDAQ:AMZNRead Amazon.com's (AMZN) Buy (B-) Rating Reaffirmed at Weiss Ratings2 hours agoAmarin (NASDAQ:AMRN) Given "Sell (D-)" Rating at Weiss RatingsMarketBeatWeiss Ratings restated a "sell (d-)" rating on shares of Amarin in a research note on Wednesday.NASDAQ:AMRNRead Amarin (NASDAQ:AMRN) Given "Sell (D-)" Rating at Weiss Ratings2 hours agoAmalgamated Financial (NASDAQ:AMAL) Earns Hold (C+) Rating from Weiss RatingsMarketBeatWeiss Ratings reiterated a "hold (c+)" rating on shares of Amalgamated Financial in a research report on Wednesday.NASDAQ:AMALRead Amalgamated Financial (NASDAQ:AMAL) Earns Hold (C+) Rating from Weiss Ratings Trending News1Archer Aviation (NYSE:ACHR) Stock Price Up 13.2% - Here's Why2Zacks Research Issues Pessimistic Outlook for NIO Earnings3AST SpaceMobile, Inc. $ASTS Shares Sold by 111 Capital4Meta Platforms (NASDAQ:META) Shares Down 2.3% Following Insider Selling5Kraken Robotics (CVE:PNG) Sets New 12-Month High - What's Next?6MBL Wealth LLC Makes New $591,000 Investment in Solid Power, Inc. $SLDP7Insider Selling: QUALCOMM (NASDAQ:QCOM) CEO Sells 150,000 Shares of Stock8Penny Stocks To Watch Now - October 4th All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Dividend Earnings Earnings Preview Estimates Guidance Insider Trade Lockup Expiration Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoALX Oncology (NASDAQ:ALXO) Given "Sell (D-)" Rating at Weiss RatingsMarketBeatNASDAQ:ALXORead ALX Oncology (NASDAQ:ALXO) Given "Sell (D-)" Rating at Weiss Ratings2 hours agoAlvotech's (ALVO) Sell (E+) Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:ALVORead Alvotech's (ALVO) Sell (E+) Rating Reiterated at Weiss Ratings2 hours agoAlumis (NASDAQ:ALMS) Earns Sell (E+) Rating from Weiss RatingsMarketBeatNASDAQ:ALMSRead Alumis (NASDAQ:ALMS) Earns Sell (E+) Rating from Weiss Ratings2 hours agoAlto Neuroscience (NYSE:ANRO) Given Sell (D-) Rating at Weiss RatingsMarketBeatNYSE:ANRORead Alto Neuroscience (NYSE:ANRO) Given Sell (D-) Rating at Weiss Ratings2 hours agoAltisource Portfolio Solutions' (ASPS) "Sell (D-)" Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:ASPSRead Altisource Portfolio Solutions' (ASPS) "Sell (D-)" Rating Reaffirmed at Weiss Ratings2 hours agoAltimmune's (ALT) "Sell (D-)" Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:ALTRead Altimmune's (ALT) "Sell (D-)" Rating Reiterated at Weiss Ratings2 hours agoWeiss Ratings Reaffirms Sell (D-) Rating for Altice USA (NYSE:ATUS)MarketBeatNYSE:ATUSRead Weiss Ratings Reaffirms Sell (D-) Rating for Altice USA (NYSE:ATUS)2 hours agoAlTi Global's (ALTI) "Sell (D-)" Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:ALTIRead AlTi Global's (ALTI) "Sell (D-)" Rating Reiterated at Weiss Ratings2 hours agoALT5 Sigma (NASDAQ:ALTS) Receives "Sell (D-)" Rating from Weiss RatingsMarketBeatNASDAQ:ALTSRead ALT5 Sigma (NASDAQ:ALTS) Receives "Sell (D-)" Rating from Weiss Ratings2 hours agoAlset's (AEI) Sell (D-) Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:AEIRead Alset's (AEI) Sell (D-) Rating Reaffirmed at Weiss Ratings2 hours agoAlphabet (NASDAQ:GOOG) Receives Buy (B) Rating from Weiss RatingsMarketBeatNASDAQ:GOOGRead Alphabet (NASDAQ:GOOG) Receives Buy (B) Rating from Weiss Ratings2 hours agoWeiss Ratings Reaffirms "Buy (B)" Rating for Alphabet (NASDAQ:GOOGL)MarketBeatNASDAQ:GOOGLRead Weiss Ratings Reaffirms "Buy (B)" Rating for Alphabet (NASDAQ:GOOGL)2 hours agoAlpha Teknova (NASDAQ:TKNO) Given Sell (D-) Rating at Weiss RatingsMarketBeatNASDAQ:TKNORead Alpha Teknova (NASDAQ:TKNO) Given Sell (D-) Rating at Weiss Ratings2 hours agoWeiss Ratings Reiterates "Sell (E+)" Rating for Alpha Technology Group (NASDAQ:ATGL)MarketBeatNASDAQ:ATGLRead Weiss Ratings Reiterates "Sell (E+)" Rating for Alpha Technology Group (NASDAQ:ATGL)2 hours agoAlpha Tau Medical (NASDAQ:DRTS) Given "Sell (D-)" Rating at Weiss RatingsMarketBeatNASDAQ:DRTSRead Alpha Tau Medical (NASDAQ:DRTS) Given "Sell (D-)" Rating at Weiss Ratings2 hours agoAlpha Metallurgical Resources' (AMR) "Sell (D)" Rating Reiterated at Weiss RatingsMarketBeatNYSE:AMRRead Alpha Metallurgical Resources' (AMR) "Sell (D)" Rating Reiterated at Weiss Ratings2 hours agoAlpha and Omega Semiconductor (NASDAQ:AOSL) Earns Sell (D-) Rating from Weiss RatingsMarketBeatNASDAQ:AOSLRead Alpha and Omega Semiconductor (NASDAQ:AOSL) Earns Sell (D-) Rating from Weiss Ratings2 hours agoWeiss Ratings Reaffirms "Sell (D-)" Rating for Alnylam Pharmaceuticals (NASDAQ:ALNY)MarketBeatNASDAQ:ALNYRead Weiss Ratings Reaffirms "Sell (D-)" Rating for Alnylam Pharmaceuticals (NASDAQ:ALNY)2 hours agoWeiss Ratings Reaffirms "Sell (E+)" Rating for Almonty Industries (NASDAQ:ALM)MarketBeatNASDAQ:ALMRead Weiss Ratings Reaffirms "Sell (E+)" Rating for Almonty Industries (NASDAQ:ALM)2 hours agoWeiss Ratings Reaffirms "Sell (D-)" Rating for Allot (NASDAQ:ALLT)MarketBeatNASDAQ:ALLTRead Weiss Ratings Reaffirms "Sell (D-)" Rating for Allot (NASDAQ:ALLT)2 hours agoAllogene Therapeutics' (ALLO) Sell (E+) Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:ALLORead Allogene Therapeutics' (ALLO) Sell (E+) Rating Reaffirmed at Weiss Ratings2 hours agoAllient (NASDAQ:ALNT) Earns Hold (C) Rating from Weiss RatingsMarketBeatNASDAQ:ALNTRead Allient (NASDAQ:ALNT) Earns Hold (C) Rating from Weiss Ratings2 hours agoWeiss Ratings Reaffirms Buy (B-) Rating for Alliant Energy (NASDAQ:LNT)MarketBeatNASDAQ:LNTRead Weiss Ratings Reaffirms Buy (B-) Rating for Alliant Energy (NASDAQ:LNT)2 hours agoAlliance Resource Partners (NASDAQ:ARLP) Given "Hold (C)" Rating at Weiss RatingsMarketBeatNASDAQ:ARLPRead Alliance Resource Partners (NASDAQ:ARLP) Given "Hold (C)" Rating at Weiss Ratings Featured Articles and OffersDatavault AI: The New AI Contender Backed by Big FundingBy Jeffrey Neal Johnson | October 1, 2025Elon Warns “America Is Broke”. Trump’s Plan Inside.From American Hartford Gold (Ad)Top 3 Dividend Achievers for October: High Yields, Growth AheadBy Thomas Hughes | October 1, 2025General Dynamics Hits New Highs: Why It Might Keep ClimbingBy Jeffrey Neal Johnson | October 2, 20253 Defense Stocks Surging as Ukraine Tensions DeepenBy Dan Schmidt | October 5, 20252013 Bitcoin miner reveals his trading system (free)From Crypto Swap Profits (Ad)Is BigBear.ai the Next Palantir? By Gabriel Osorio-Mazilli | October 3, 2025NVIDIA Breaks Out to New Highs: What Comes Next?By Thomas Hughes | October 2, 2025 Sector NewsAerospace NewsArtificial Intelligence NewsAutomotive NewsConsumer Product NewsEnergy NewsFinancial Services NewsHealthcare NewsIndustrial NewsMedia NewsManufacturing NewsTechnology NewsTransportation NewsRetail News Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
